Jasmin Tiro to Vaginal Smears
This is a "connection" page, showing publications Jasmin Tiro has written about Vaginal Smears.
Connection Strength
1.238
-
Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine. 2011 Jun 06; 29(25):4238-43.
Score: 0.385
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
Score: 0.192
-
Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care. 2010 Mar; 48(3):249-59.
Score: 0.089
-
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008 Nov 15; 113(10 Suppl):3013-30.
Score: 0.082
-
Does patient health and hysterectomy status influence cervical cancer screening in older women? J Gen Intern Med. 2008 Nov; 23(11):1822-8.
Score: 0.081
-
Timing of Colposcopy and Risk of Cervical Cancer. Obstet Gynecol. 2023 11 01; 142(5):1125-1134.
Score: 0.057
-
Provider beliefs in effectiveness and recommendations for primary HPV testing inĀ 3 health-care systems. JNCI Cancer Spectr. 2023 01 03; 7(1).
Score: 0.054
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
Score: 0.054
-
Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 02; 12(3):3705-3717.
Score: 0.053
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
Score: 0.050
-
De-implementation of cervical cancer screening before age 21. Prev Med. 2021 12; 153:106815.
Score: 0.050
-
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
Score: 0.047
-
Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits. J Med Screen. 2020 09; 27(3):146-156.
Score: 0.044